drugset
drugset / Trial / NCT05425420

Single Dose IV Methadone for Post-Op Pain

NCT05425420 ↗

Phase 1/2 Completed 22 enrolled Kanecia Obie Zimmerman
NaSingle-groupOpen-labelOther

Summary

Single-center, open label, single-session study to evaluate methadone pharmacokinetics and pharmacodynamic in adults.

Timeline

Start
2023-08-11
Primary completion
2024-01-20
Completion
2024-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.